CADTH Canadian Drug Expert Committee recommendation : indication : vision loss, inherited retinal dystrophy. Voretigene neparvovec (Luxturna -- Novartis Pharmaceuticals Canada Inc.)

MLA

Canadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee recommendation : indication : vision loss, inherited retinal dystrophy. Voretigene neparvovec (Luxturna -- Novartis Pharmaceuticals Canada Inc.). First edition. Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2020.

APA

Canadian Agency for Drugs and Technologies in Health. (2020). CADTH Canadian Drug Expert Committee recommendation : indication : vision loss, inherited retinal dystrophy. Voretigene neparvovec (Luxturna -- Novartis Pharmaceuticals Canada Inc.). First edition. Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health.

Chicago

Canadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee recommendation : indication : vision loss, inherited retinal dystrophy. Voretigene neparvovec (Luxturna -- Novartis Pharmaceuticals Canada Inc.). First edition. Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2020.